These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27709817)

  • 1. Tunable Probes with Direct Fluorescence Signals for the Constitutive and Immunoproteasome.
    Dubiella C; Cui H; Groll M
    Angew Chem Int Ed Engl; 2016 Oct; 55(42):13330-13334. PubMed ID: 27709817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential peptidic proteasome inhibitors by incorporation of an electrophilic trap based on amino acid derived α-substituted sulfonyl fluorides.
    Herrero Alvarez N; van de Langemheen H; Brouwer AJ; Liskamp RMJ
    Bioorg Med Chem; 2017 Oct; 25(19):5055-5063. PubMed ID: 28734665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent and Highly Selective Inhibitors of the Proteasome Trypsin-like Site by Incorporation of Basic Side Chain Containing Amino Acid Derived Sulfonyl Fluorides.
    Artschwager R; Ward DJ; Gannon S; Brouwer AJ; van de Langemheen H; Kowalski H; Liskamp RMJ
    J Med Chem; 2018 Jun; 61(12):5395-5411. PubMed ID: 29782167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Design of Fluorogenic Substrates Selective for Human Proteasome Subunits.
    Maurits E; Degeling CG; Kisselev AF; Florea BI; Overkleeft HS
    Chembiochem; 2020 Nov; 21(22):3220-3224. PubMed ID: 32598532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomes.
    Villoutreix BO; Khatib AM; Cheng Y; Miteva MA; Maréchal X; Vidal J; Reboud-Ravaux M
    Oncotarget; 2017 Feb; 8(6):10437-10449. PubMed ID: 28060729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of the immunoproteasome by ligand-induced crosslinking of the active site.
    Dubiella C; Cui H; Gersch M; Brouwer AJ; Sieber SA; Krüger A; Liskamp RM; Groll M
    Angew Chem Int Ed Engl; 2014 Oct; 53(44):11969-73. PubMed ID: 25244435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating the catalytic subunit composition of distinct proteasome subtypes: a crosslinking approach employing bifunctional activity-based probes.
    Cornish Carmony K; Sharma LK; Lee DM; Park JE; Lee W; Kim KB
    Chembiochem; 2015 Jan; 16(2):284-92. PubMed ID: 25477005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome Subunit Selective Activity-Based Probes Report on Proteasome Core Particle Composition in a Native Polyacrylamide Gel Electrophoresis Fluorescence-Resonance Energy Transfer Assay.
    de Bruin G; Xin BT; Florea BI; Overkleeft HS
    J Am Chem Soc; 2016 Aug; 138(31):9874-80. PubMed ID: 27428761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of human immuno- and constitutive proteasomes inhibitors.
    Richy N; Sarraf D; Maréchal X; Janmamode N; Le Guével R; Genin E; Reboud-Ravaux M; Vidal J
    Eur J Med Chem; 2018 Feb; 145():570-587. PubMed ID: 29339252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors.
    Maccari R; Ettari R; Adornato I; Naß A; Wolber G; Bitto A; Mannino F; Aliquò F; Bruno G; Nicolò F; Previti S; Grasso S; Zappalà M; Ottanà R
    Bioorg Med Chem Lett; 2018 Feb; 28(3):278-283. PubMed ID: 29292224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonpeptidic Selective Inhibitors of the Chymotrypsin-Like (β5 i) Subunit of the Immunoproteasome.
    Sosič I; Gobec M; Brus B; Knez D; Živec M; Konc J; Lešnik S; Ogrizek M; Obreza A; Žigon D; Janežič D; Mlinarič-Raščan I; Gobec S
    Angew Chem Int Ed Engl; 2016 May; 55(19):5745-8. PubMed ID: 27037901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoproteasome-selective inhibitors: the future of autoimmune diseases?
    Zhang C; Zhu H; Shao J; He R; Xi J; Zhuang R; Zhang J
    Future Med Chem; 2020 Feb; 12(4):269-272. PubMed ID: 31983229
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes.
    de Bruin G; Huber EM; Xin BT; van Rooden EJ; Al-Ayed K; Kim KB; Kisselev AF; Driessen C; van der Stelt M; van der Marel GA; Groll M; Overkleeft HS
    J Med Chem; 2014 Jul; 57(14):6197-209. PubMed ID: 25006746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Biochemical Evaluation of Warhead-Decorated Psoralens as (Immuno)Proteasome Inhibitors.
    Schiffrer ES; Proj M; Gobec M; Rejc L; Šterman A; Mravljak J; Gobec S; Sosič I
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33445542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptido sulfonyl fluorides as new powerful proteasome inhibitors.
    Brouwer AJ; Jonker A; Werkhoven P; Kuo E; Li N; Gallastegui N; Kemmink J; Florea BI; Groll M; Overkleeft HS; Liskamp RM
    J Med Chem; 2012 Dec; 55(24):10995-1003. PubMed ID: 23170994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetradehydrohalicyclamine B, a new proteasome inhibitor from the marine sponge Acanthostrongylophora ingens.
    Kato H; El-Desoky AH; Takeishi Y; Nehira T; Angkouw ED; Mangindaan REP; de Voogd NJ; Tsukamoto S
    Bioorg Med Chem Lett; 2019 Jan; 29(1):8-10. PubMed ID: 30455150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A panel of subunit-selective activity-based proteasome probes.
    Verdoes M; Willems LI; van der Linden WA; Duivenvoorden BA; van der Marel GA; Florea BI; Kisselev AF; Overkleeft HS
    Org Biomol Chem; 2010 Jun; 8(12):2719-27. PubMed ID: 20449511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoproteasome-selective inhibitors: An overview of recent developments as potential drugs for hematologic malignancies and autoimmune diseases.
    Xi J; Zhuang R; Kong L; He R; Zhu H; Zhang J
    Eur J Med Chem; 2019 Nov; 182():111646. PubMed ID: 31521028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probes.
    Carmony KC; Lee DM; Wu Y; Lee NR; Wehenkel M; Lee J; Lei B; Zhan CG; Kim KB
    Bioorg Med Chem; 2012 Jan; 20(2):607-13. PubMed ID: 21741845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,2,4-Oxadiazoles identified by virtual screening and their non-covalent inhibition of the human 20S proteasome.
    Maréchal X; Genin E; Qin L; Sperandio O; Montes M; Basse N; Richy N; Miteva MA; Reboud-Ravaux M; Vidal J; Villoutreix BO
    Curr Med Chem; 2013; 20(18):2351-62. PubMed ID: 23531222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.